RNA - Avidity Biosciences  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RNA is currently covered by 7 analysts with an average price target of $64.23. This is a potential upside of $22.93 (55.52%) from yesterday's end of day stock price of $41.3.

Avidity Biosciences 's activity chart (see below) currently has 17 price targets and 46 ratings on display. The stock rating distribution of RNA is 96.88% BUY and 3.13% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.37% with an average time for these price targets to be met of 447.71 days.

Highest price target for RNA is $65, Lowest price target is $60, average price target is $64.23.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 13-Nov-2024. First documented stock forecast 07-Jul-2020.

Currently out of the existing stock ratings of RNA, 31 are a BUY (96.88%), 1 are a HOLD (3.13%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$60

$16.97 (39.44%)

$60

19 days ago
(13-Nov-2024)

12/15 (80%)

$5.97 (11.05%)

228

Buy

$65

$21.97 (51.06%)

$45

1 months 2 days ago
(30-Oct-2024)

8/9 (88.89%)

$21.78 (50.39%)

299

Buy

$18

$-25.03 (-58.17%)

1 years 23 days ago
(09-Nov-2023)

3/3 (100%)

$12.52 (228.47%)

873

Buy

$30

$-13.03 (-30.28%)

$30

1 years 3 months 23 days ago
(09-Aug-2023)

8/8 (100%)

$20.65 (220.86%)

581

Buy

$20

$10.67 (114.36%)

$20

1 years 6 months 11 days ago
(22-May-2023)

0/2 (0%)

$7.92 (65.56%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RNA (Avidity Biosciences ) average time for price targets to be met?

On average it took 447.71 days on average for the stock forecasts to be realized with a an average price target met ratio 69.37

Which analyst has the current highest performing score on RNA (Avidity Biosciences ) with a proven track record?

JUDAH FROMMER

Which analyst has the current lower performing score on RNA (Avidity Biosciences ) with a proven track record?

YANAN ZHU

Which analyst has the most public recommendations on RNA (Avidity Biosciences )?

Judah Frommer works at MORGAN STANLEY and has 5 price targets and 11 ratings on RNA

Which analyst is the currently most bullish on RNA (Avidity Biosciences )?

Steven Seedhouse with highest potential upside - $27.97

Which analyst is the currently most reserved on RNA (Avidity Biosciences )?

Joseph Schwartz with lowest potential downside - -$25.03

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?